Related Experiment Video
Updated: Jun 28, 2026

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
Published on: November 8, 2024
Factor H binds to platelet integrin alphaIIbbeta3
Zakar Mnjoyan1, Jun Li, Vahid Afshar-Kharghan
1MD Anderson Cancer Center, Houston, TX 77030, USA.
Factor H is a plasma protein that regulates activity of the alternative complement pathway in plasma and on cell surface. Binding of factor H to a cell surface protects that cell against complement-induced damage. Factor H binds to glycosoaminoglycans, surface-immobilized C3b, L selectin, and integrins such as alpha(M)beta(1) (a direct binding) or alpha(V)beta(3) (an indirect binding mediated through intermediary plasma proteins). We studied the binding of factor H to platelets and to integrin alpha(IIb)beta(3) (glycoprotein IIb-IIIa), the most abundant integrin on platelets. We measured binding of purified factor H to platelets or heterologous cells expressing recombinant alpha(IIb)beta(3) using flow cytometry. We also measured binding of factor H to alpha(IIb)beta(3) in cell free systems using either surface plasmon resonance or enzyme-linked immunosorbent assay. We found that factor H directly binds to alpha(IIb)beta(3) and this binding has a dissociation constant (Kd) of 131 +/- 60.9 nM and is not dependent on active conformation of alpha(IIb)beta(3) or on the presence of cations. Considering the high affinity of this interaction, the abundance of alpha(IIb)beta(3) integrin on platelets, and the high concentration of factor H in plasma, alpha(IIb)beta(3) provides a constitutive presence of factor H on platelets. Activation of platelets increases platelet-bound factor; however, this increase in binding of factor H cannot be explained by additional binding of factor H to alpha(IIb)beta(3) and perhaps involves other binding sites for factor H on platelets.
Factor H is a plasma protein that regulates activity of the alternative complement pathway in plasma and on cell surface. Binding of factor H to a cell surface protects that cell against complement-induced damage. Factor H binds to glycosoaminoglycans, surface-immobilized C3b, L selectin, and integrins such as alpha(M)beta(1) (a direct binding) or alpha(V)beta(3) (an indirect binding mediated through intermediary plasma proteins). We studied the binding of factor H to platelets and to integrin alpha(IIb)beta(3) (glycoprotein IIb-IIIa), the most abundant integrin on platelets. We measured binding of purified factor H to platelets or heterologous cells expressing recombinant alpha(IIb)beta(3) using flow cytometry. We also measured binding of factor H to alpha(IIb)beta(3) in cell free systems using either surface plasmon resonance or enzyme-linked immunosorbent assay. We found that factor H directly binds to alpha(IIb)beta(3) and this binding has a dissociation constant (Kd) of 131 +/- 60.9 nM and is not dependent on active conformation of alpha(IIb)beta(3) or on the presence of cations. Considering the high affinity of this interaction, the abundance of alpha(IIb)beta(3) integrin on platelets, and the high concentration of factor H in plasma, alpha(IIb)beta(3) provides a constitutive presence of factor H on platelets. Activation of platelets increases platelet-bound factor; however, this increase in binding of factor H cannot be explained by additional binding of factor H to alpha(IIb)beta(3) and perhaps involves other binding sites for factor H on platelets.
More Related Videos
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...

